Wang Klara, Tamayo Marielou G, Penner Tiffany V, Cook Bradley W M, Court Deborah A, Theriault Steven S
Cytophage Technologies, Inc., Winnipeg, Manitoba, Canada.
Department of Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada.
Microbiol Resour Announc. 2020 Mar 26;9(13):e01600-19. doi: 10.1128/MRA.01600-19.
is an opportunistic pathogen that causes hospital-acquired infections in immunocompromised patients. Here, we describe vB_EclM_CIP9, a novel phage that infects a multidrug-resistant isolate of Phage vB_EclM_CIP9 is a myovirus that has a 174,924-bp genome, with 296 predicted open reading frames.
是一种机会致病菌,可在免疫功能低下的患者中引起医院获得性感染。在此,我们描述了vB_EclM_CIP9,一种新型噬菌体,它感染大肠杆菌的多重耐药菌株。噬菌体vB_EclM_CIP9是一种肌尾噬菌体,其基因组有174,924个碱基对,预测有296个开放阅读框。